Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Müzeyyen Ugur, Lyes Derouiche, Dominique Massotte
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Diversity of molecular targets and signaling pathways for CBD
Douglas Lamounier de Almeida, Lakshmi A. Devi
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 194
CC Chemokine Family Members’ Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury—A Review of Clinical and Experimental Findings
A Ciechanowska, Joanna Mika
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3788-3788
Open Access | Times Cited: 10
Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Li Zhang, Jiangtao Zhang, Lihua Hang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 57
Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity
Ujendra Kumar, Sneha Singh
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2568-2568
Open Access | Times Cited: 53
The Effects of Opioids on HIV Neuropathogenesis
Aniella Murphy, John M. Barbaro, Pablo Martínez-Aguado, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 54
Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain
Katarzyna Pawlik, Joanna Mika
Molecules (2023) Vol. 28, Iss. 15, pp. 5766-5766
Open Access | Times Cited: 15
The Life Cycle of the Mu-Opioid Receptor
Javier Cuitavi, Lucía Hipólito, Meritxell Canals
Trends in Biochemical Sciences (2020) Vol. 46, Iss. 4, pp. 315-328
Open Access | Times Cited: 38
Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain
Katarzyna Pawlik, A Ciechanowska, Katarzyna Ciapała, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy
Klaudia Kwiatkowski, Katarzyna Pawlik, Katarzyna Ciapała, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 27
<p>Electroacupuncture decreases Netrin-1-induced myelinated afferent fiber sprouting and neuropathic pain through &mu;-opioid receptors</p>
Hongping Li, Wen Su, Yang Shu, et al.
Journal of Pain Research (2019) Vol. Volume 12, pp. 1259-1268
Open Access | Times Cited: 25
Antagonism of the mu-delta opioid receptor heterodimer enhances opioid antinociception by activating Src and calcium/calmodulin-dependent protein kinase II signaling
Attila Keresztes, Keith M. Olson, Paul Nguyen, et al.
Pain (2021) Vol. 163, Iss. 1, pp. 146-158
Open Access | Times Cited: 18
Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach
Marie Emilie Hovah, Ulrike Holzgrabe
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2545-2599
Open Access | Times Cited: 2
Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities
Marion Gaborit, Dominique Massotte
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 994-1013
Open Access | Times Cited: 16
Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders
Miguel Pérez de la Mora, Dasiel O. Borroto‐Escuela, Minerva Crespo‐Ramírez, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1826-1826
Open Access | Times Cited: 11
Endogenous opiates and behavior: 2019
Richard J. Bodnar
Peptides (2021) Vol. 141, pp. 170547-170547
Closed Access | Times Cited: 15
Knowing the Enemy Is Halfway towards Victory: A Scoping Review on Opioid-Induced Hyperalgesia
Tiago J. Sampaio-Cunha, Isabel Martins
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 6161-6161
Open Access | Times Cited: 10
Utilization of Biased G Protein-Coupled Receptor Signaling towards Development of Safer and Personalized Therapeutics
Metehan Ilter, Samman Mansoor, Özge Şensoy
Molecules (2019) Vol. 24, Iss. 11, pp. 2052-2052
Open Access | Times Cited: 15
Moxie begets MOXI: The journey to a novel hypothesis about Mu-opioid and OXytocin system Interactions
Khalin E. Nisbett
Comprehensive Psychoneuroendocrinology (2024) Vol. 19, pp. 100244-100244
Open Access | Times Cited: 1
GPCR oligomerization as a target for antidepressants: Focus on GPR39
Katarzyna Młyniec, Dominika Siodłak, Urszula Doboszewska, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107842-107842
Closed Access | Times Cited: 10
Curcumin attenuates morphine dependence by modulating μ-opioid receptors and glial cell-activated neuroinflammation in rat
Mohammad Abbas Sheikholeslami, Siavash Parvardeh, Shiva Ghafghazi, et al.
Neuropeptides (2022) Vol. 98, pp. 102318-102318
Closed Access | Times Cited: 7
The Possible Role of MOPr-DOPr Heteromers and Its Regulatory Protein RTP4 at Sensory Neurons in Relation to Pain Perception
Wakako Fujita
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 9
Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
Antonios Drakopoulos, Dimitrios Moianos, Georgia‐Myrto Prifti, et al.
ChemMedChem (2022) Vol. 17, Iss. 14
Closed Access | Times Cited: 6
Design of Analgesic Trivalent Peptides with Low Withdrawal Symptoms: Probing the Antinociceptive Profile of Novel Linear and Cyclic Peptides as Opioid Pan Ligands
Azzurra Stefanucci, Paola Minosi, Stefano Pieretti, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 506-515
Closed Access | Times Cited: 3
Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities
Robert Root‐Bernstein, Beth Churchill
Life (2021) Vol. 11, Iss. 11, pp. 1217-1217
Open Access | Times Cited: 7
Effect of Methadone and Tramadol Opioids on Stem Cells Based on Integrated Plasmonic-Ellipsometry Technique
Tannaz Asadishad, Foozieh Sohrabi, Maryam Hakimi, et al.
Journal of lasers in medical sciences (2021) Vol. 12, Iss. 1, pp. e46-e46
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top